Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Delcath’s Melblez Chemosaturation System To Face ODAC Scrutiny

Related Content

Aveo’s Tivozanib Will Face Challenging Survival Data At ODAC Review

Feb 26 2013

Bristol Basks In Broad Ipilimumab Label, Sets High Price

Mar 25 2011

Glaxo’s Emerging BRAF/MEK Melanoma Combo Threatens Roche’s <em>Zelboraf</em>

Nov 26 2012

Speedy Approval Of Roche's Zelboraf Puts Pressure On Bristol's Yervoy

Aug 17 2011

Related Companies

Delcath Systems, Inc.

Bristol Myers Squibb Company

Roche Holding AG

GSK plc

AVEO Pharmaceuticals, Inc.

Additional Topics

United States Advisory Committees BioPharmaceutical Medical Device Combination Products

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window